Bainbridge Island, Washington--(Newsfile Corp. - July 27, 2022) - BioViva, a firm developing gene therapy treatments as a means of reducing aging, is announcing its latest advances as it continues its ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

In September 2015, then 44 year-old CEO of BioViva USA Inc. Elizabeth Parrish received two of her own company's experimental gene therapies: one to protect against loss of muscle mass with age, ...

Antiaging gene therapies to overexpress TERT and Follistatin were used in a mouse model. The mice saw a 41 and 32% increase in median life span. The study also used a novel viral vector, ...

Liz Parrish runs Bioviva and they are working towards antiaging gene therapy. She also reviewed the current state of this work. There are over 300 studies of gene therapy targeting various aspects of ...